Table of Contents
Table of Contents
Preface
Chapter 1. Zika Virus: Basics About the Disease
Sarah A. Lister
Chapter 2. Zika Virus in Latin America and the Caribbean: U.S. Policy Considerations
Clare Ribando Seelke, Tiaji Salaam-Blyther and June S. Beittel
Chapter 3. Zika Response Funding: Request and Congressional Action
Susan B. Epstein and Sarah A. Lister
Chapter 4. Emerging Infectious Diseases: Preliminary Observations on the Zika Virus Outbreak
United States Government Accountability Office
Chapter 5. Testimony of Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health. Hearing on ”Examining the U.S. Public Health Response to the Zika Virus”
Chapter 6. Testimony of Joseph M. Conlon, Technical Advisor, American Mosquito Control Association. Hearing on ”Examining the U.S. Public Health Response to the Zika Virus”
Chapter 7. Statement of Dr. Luciana Borio, Acting Chief Scientist, U.S. Food and Drug Administration. Hearing on ”Examining the U.S. Public Health Response to the Zika Virus”
Chapter 8. Testimony of Dr. Thomas R. Frieden, Director, Centers for Disease Control and Prevention. Hearing on ”Examining the U.S. Public Health Response to the Zika Virus”
Chapter 9. Testimony of Lawrence O. Gostin, Faculty Director, O’Neill Institute for National and Global Health Law. Hearing on ”Examining the U.S. Public Health Response to the Zika Virus”
Chapter 10. Testimony of Dr. Kacey C. Ernst, Associate Professor, University of Arizona. Hearing on ”Science of Zika: The DNA of an Epidemic”
Chapter 11. Testimony of Dr. Daniel Neafsey, Associate Director, Genomic Center for Infectious Disease, Broad Institute of MIT and Harvard. Hearing on ”Science of Zika: The DNA of an Epidemic”
Chapter 12. Statement of Hadyn Parry, Chief Executive Officer, Oxitec. Hearing on ”Science of Zika: The DNA of an Epidemic”
Related Nova Publication
Index
